1. Introduction |
2. Endothelial cell and monocyte migration assays |
3. Endothelial cell proliferation assays |
4. 3D models of vascular morphogenesis |
5. Aortic ring assay |
6. Tumor microvessel density and histopathological growth patterns in tumors |
7. Assessment of intussusceptive angiogenesis |
8. In vivo sprouting lymphangiogenic assay and AAV-mediated gene transfer of vascular endothelial growth factor c (VEGFC) |
9. Assay for pericyte recruitment to endothelial cell-lined tubes, capillary assembly, and maturation |
10. EC co-culture spheroids |
11. Endothelial cell metabolism |
12. Endothelial cell precursors |
13. Microfluidic assays |
14. Flow cytometry and cell sorting assays |
15. Loss-of-function approaches in the developing zebrafish |
16. Chorioallantoic membrane assays |
17. Murine allantois assay |
18. In vivo angiogenesis plug assay |
19. In vivo vascular network forming assay |
20. Developing mouse retinal vasculature—tip cells |
21. Corneal angiogenesis assays |
22. Mouse oxygen-induced retinopathy model |
23. Laser-induced choroidal neovascularization mouse model |
24. Transparent window preparations for angiogenesis studies in mice |
25. The RIP1-Tag2 transgenic mouse model |
26. The MMTV-PyMT breast cancer model |
27. Tumor implantation models |
28. Mouse hind limb ischemia model |
29. Large animal models for myocardial angiogenesis |
30. Guidelines for purity of recombinant proteins in angiogenesis assays |
31. Conclusions |
Introduction
Endothelial cell and monocyte migration assays
Types of assays
Limitations and challenges
Concluding remarks
Endothelial cell proliferation assays
Types of proliferation assays
Limitations and challenges
Concluding remarks
3D models of vascular morphogenesis
Assay | Process | |||||
---|---|---|---|---|---|---|
Sprouting | Lumen formation | Anastomosis | Pericyte recruitment | Perfusion | Pruning | |
Fibrin bead assay | ✓ | ✓ | ✓ | ✓ | ||
Collagen lumen assay | ✓ | ✓ | ||||
Retina explant assay | ✓ | ✓ | ✓ | |||
Vascularized micro-organ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Types of assays
Limitations and challenges
Concluding remarks
Aortic ring assay
Benefits and strengths of the aortic ring assay
Assay overview
Quantitative analysis of angiogenesis in aortic cultures
Critical points
Limitations and challenges
Concluding Remarks
Tumor microvessel density and histopathological growth patterns in tumors
Histopathological growth patterns
Concluding remarks
Assessment of intussusceptive angiogenesis
The concept of intussusception and the methodological challenge
Limitations and challenges
Concluding remarks
In vivo sprouting lymphangiogenic assay and AAV-mediated gene transfer of vascular endothelial growth factor c (VEGFC)
Description of the ear sponge assay and AAV generation/tissue transduction
Applications, benefits, and strengths of the assay: analysis of lymphangiogenesis and angiogenesis
Limitations and challenges
Concluding remarks
Assay for pericyte recruitment to endothelial cell-lined tubes, capillary assembly, and maturation
Benefits and strengths of the assay
Assay overview
Critical steps in the assay
Limitations and challenges
Concluding remarks
EC co-culture spheroids
Strengths and benefits of the three-dimensional co-culture EC spheroids
Assay overview and types of assays
Limitations and challenges
Concluding remarks
Endothelial cell metabolism
Tracer metabolomics
Experimental tracer metabolomics setup of EC
Mass spectrometry
Data processing
Radioactive tracer-based assays
Measurements of extracellular acidification rate and mitochondrial respiration using a Seahorse XF analyzer
Limitations and challenges, problems and pitfalls in probing EC metabolism
Endothelial cell precursors
Assays to identify endothelial stem and progenitor cells
Limitations and challenges
Concluding remarks
Microfluidic assays
Development and capabilities
Advantages of microfluidics for angiogenesis studies
Limitations and challenges
Concluding remarks
Flow cytometry and cell sorting assays
Types of assays
Limitations and challenges
Concluding remarks
Loss-of-function approaches in the developing zebrafish
Morpholinos
Genetic mutants
Assessing vascular phenotypes in loss-of-function models
Where is the gene expressed?
Assessing general morphology and development in morphants or mutants
Assessing circulatory flow and cardiac function
Assessing vascular patterning
Concluding remarks
Chorioallantoic membrane assays
In ovo CAM assays
Ex ovo CAM assays
Angiogenesis platform using a cubic artificial eggshell with patterned blood vessels
Assessing vascular patterning
The experimental chicken embryo tumor model
References | |
---|---|
Developmental angiogenesis
| |
Differentiation of vascular endothelium | |
Membrane proteome associated with the vasculature | [366] |
Gene transfer/global gene expression | |
Metabolic profiling | [659] |
Transcriptome analysis in the “wound model” | [660] |
Vascular and endothelial cell targets from isolated chicken membranes | [367] |
Lymphangiogenesis
| |
Prox-1 in the lymphatic endothelial cells | |
Ingrowth of lymphatics into the tumors | [662] |
Embryonic lymphangiogenesis | [663] |
Vasomodulating therapies
| |
Radiosensitizing activity | |
Microbeam radiation therapy | [667] |
Photodynamic therapy and diagnosis | |
Tumor angiogenesis
| |
Tumor growth in the CAM | |
Experimental metastasis | |
Interstitial pO2 gradients in solid tumors | |
Accessing molecules activity
| |
Growth factor (receptors) inhibitors; endothelium-targeting molecules | |
Metal-based compounds | |
Inflammatory and tumor cells or purified effector molecules | [692] |
Pro-angiogenic molecules | [693] |
Stem cells
| |
Human mesenchymal stem cells | |
Human skin-derived stem cells | [697] |
Drug delivery, nanoparticles
| |
Drug delivery for cancer treatment | |
Visible laser irradiation + gold nanoparticles | [700] |
Screening of nanocarrier vehicles | |
Engineering
| |
Tissue engineering and biomaterials |
Functional genomics analysis using the chicken CAM model
Limitations and challenges
The CAM as a screening platform
Concluding remarks
Murine allantois assay
Overview assay
Limitations and challenges
Concluding remarks
In vivo angiogenesis plug assay
The in vivo plug assay method
Key steps in 3D imaging and analyses
Limitations and challenges
Concluding remarks
In vivo vascular network forming assay
Background/history
Assay overview
Visualizing and quantifying vessels
Distinguishing human from murine vessels
Longitudinal analyses
Advantages
Limitations and challenges
Concluding remarks
Developing mouse retinal vasculature—tip cells
Visualization of cellular markers and gene expression
Analysis of tip cells
Network analysis of retinal vasculature
Limitations and challenges
Concluding remarks
Corneal angiogenesis assays
Assay overview
Limitations and challenges
Concluding remarks
Mouse oxygen-induced retinopathy model
Assay overview
Limitations and challenges
Concluding remarks
Laser-induced choroidal neovascularization mouse model
Laser CNV model advantages and limitations
Assay overview
Limitations and challenges
Concluding remarks
Transparent window preparations for angiogenesis studies in mice
References | |
---|---|
Development of novel imaging techniques
| |
Direct measurement of interstitial diffusion and convection of albumin using fluorescence photobleaching | [707] |
Tumor induction of VEGF promoter activity in stromal cells | [506] |
Interstitial pH and pO2 gradients in solid tumors in vivo | [505] |
In vivo measurement of gene expression, angiogenesis, and physiological function in tumors | [487] |
Two-photon fluorescence correlation microscopy to reveal transport in tumors | [498] |
Quantum dots to spectrally distinguish multiple species within the tumor milieu in vivo | [490] |
Three-dimensional in vivo microscopy using optical frequency domain imaging | [485] |
Simultaneous measurement of RBC velocity, flux, hematocrit, and shear rate in vivo | [495] |
In vivo validation of MRI vessel caliber index with intravital optical microscopy in a mouse brain tumor model | [515] |
Video-rate resonant scanning multiphoton microscopy | [496] |
Next-generation in vivo optical imaging with short-wave infrared quantum dots | [708] |
Analysis of vessel function
| |
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | [501] |
Effect of tumor–host interactions on distal angiogenesis and tumor growth | [709] |
Kinetics of vascular normalization in response to VEGFR2 blockade | [510] |
pH/pO
2
| |
Calibration and application of fluorescence ratio imaging of pH gradients | [503] |
Noninvasive measurement of microvascular and interstitial oxygen profiles | [504] |
Simultaneous in vivo high-resolution measurements of interstitial pH and pO2 gradients | [505] |
Extracellular matrix and interstitial transport
| |
Fluorescence photobleaching with spatial Fourier analysis for measurement of diffusion | [502] |
Dynamic imaging of collagen in tumors in vivo using second-harmonic generation | [491] |
In vivo imaging of ECM remodeling by tumor-associated fibroblasts | [492] |
Angiotensin inhibition enhances drug delivery by decompressing tumor blood vessels | [500] |
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy | [481] |
Immune cells
| |
VEGF and bFGF regulate natural killer cell adhesion to tumor endothelium | [497] |
Ly6Clow monocytes drive immunosuppression and confer resistance to anti-VEGFR2 therapy | [511] |
Analysis of lymphatic vessel function
| |
Conventional and high-speed intravital multiphoton laser scanning microscopy | [508] |
Lymphatic metastasis in the absence of functional intratumor lymphatics | [710] |
A genetic Xenopus laevis tadpole model to study lymphangiogenesis | [711] |
Investigation of the lack of angiogenesis in the formation of lymph node metastases | [486] |
Drug delivery, nanoparticles
| |
Vascular normalization improves the delivery of nanomedicines in a size-dependent manner | [499] |
Compact high-quality CdSe-CdS core–shell nanocrystals with narrow emission linewidths and suppressed blinking | [489] |
Magneto-fluorescent core–shell supernanoparticles | [712] |
Engineered vasculature
| |
Tissue engineering: creation of long-lasting blood vessels | [407] |
Paradoxical effects of PDGF-BB overexpression in EC in vivo | [713] |
Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis | [509] |
Generation of functionally competent durable engineered blood vessels from human pluripotent stem cells | [398] |
Mathematical analysis of angiogenesis
| |
Scale-invariant behavior and vascular network formation in normal and tumor tissue | [517] |
Cancer, angiogenesis, and fractals | [519] |
Scaling rules for diffusive drug delivery in tumor and normal tissues | [518] |
Assessing therapies
| |
Herceptin acts as an anti-angiogenic cocktail | [714] |
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma | [478] |
Vascular endothelial protein tyrosine phosphatase inhibition in tumor vasculature and metastatic progression | [512] |
A cerebellar window for intravital imaging of medulloblastoma in mice | [479] |
Tissue isolation chambers
| |
Implantable tissue isolation chambers for analyzing tumor dynamics in vivo | [493] |